Anzeige
Mehr »
Donnerstag, 01.01.2026 - Börsentäglich über 12.000 News
Schon +250% im Plus - warum diese Goldstory gerade erst startet!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PUQN | ISIN: GG00BKTRRM22 | Ticker-Symbol: 0BM
Frankfurt
30.12.25 | 08:06
1,750 Euro
-0,57 % -0,010
1-Jahres-Chart
RTW BIOTECH OPPORTUNITIES LTD Chart 1 Jahr
5-Tage-Chart
RTW BIOTECH OPPORTUNITIES LTD 5-Tage-Chart
RealtimeGeldBriefZeit
1,8201,92030.12.25

Aktuelle News zur RTW BIOTECH OPPORTUNITIES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
18.12.25RTW Biotech invests USD5.9 million in Yarrow Bioscience funding round1
18.12.25Morning briefing: RTW Biotech launches Yarrow Bioscience; Nippon Active sells its biggest holding; shrinking Bellevue Healthcare ploughs on with buybacks; plus AEET1
18.12.25RTW Biotech Opp. - New investment in Yarrow Bioscience-
12.12.25RTW Biotech Opp. - Monthly Valuation Update and Factsheet-
04.12.25RTW Biotech Opp. - Inclusion in FTSE 250 Index-
01.12.25RTW Biotech Opp. - Total Voting Rights1
25.11.25RTW Biotech Opp. - Retail Investor Webinar-
RTW BIOTECH OPPORTUNITIES Aktie jetzt für 0€ handeln
14.11.25RTW Biotech Opp. - Monthly Valuation Update and Factsheet-
07.11.25RTW Biotech notes investee Evommune's USD150 million IPO raise1
07.11.25RTW Biotech Opp. - Evommune announces $150 million IPO-
05.11.25Saba puts fresh capital into RTW Biotech's rally (and lifts Smithson stake to 16%)3
03.11.25RTW Biotech Opp. - Total Voting Rights-
31.10.25RTW Biotech announces royalty funding agreement with Savara4
31.10.25RTW Biotech Opp. - Royalty Funding Agreement with Savara Inc.1
27.10.25RTW Biotech hails Novartis acquisition of investee Avidity10
27.10.25RTW Biotech Opp. - Novartis to acquire Avidity Biosciences6
20.10.25IN BRIEF: RTW Biotech Opportunities extends buyback by USD15 million1
20.10.25M&A: RTW Biotech uses recent bid gains to throw $15m more into buying back its "materially" cheap shares1
20.10.25RTW Biotech Opp. - Capital Allocation Plan based on M&A successes-
15.10.25RTW Biotech invests USD7.4 million in financing round for Kailera1
Weiter >>
38 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1